_2_edited_edited.png)
ABOUT
_2_edited.png)
ClinActis is a trusted, full-service contract research organisation (CRO), delivering comprehensive clinical research services across the Asia Pacific (APAC) region. Our expertise in clinical research project management supports biotech, pharmaceutical, medical device, and medical nutrition companies, including those based internationally or in the United States who are looking to expand globally.
KEY FACTS
Founded in 2009 and headquartered in Singapore, ClinActis is a leading contract research organisation (CRO) that has established itself as a leading provider of clinical trial services across the Asia Pacific region. With a senior management team boasting over 50 years of combined experience in clinical research, we bring unmatched expertise and regional insight to every project.
50+
Years
50+ cumulative years experience managing phase I-IV clinical trials in Asia Pacific
100+ Clinical projects successfully completed
100+
Projects
500+ Sites in ClinActis site database and network
500+
Sites
40+ Sponsors have trusted ClinActis to manage their clinical research projects since 2009.
40+
Sponsors
SERVICES
ClinActis provides high-quality, cost-effective clinical research project management services tailored to meet the unique needs of clients in clinical research across Asia and the APAC region. Our solutions ensure efficiency, compliance, and optimal outcomes for all your clinical research needs.
Product Development Strategy in Asia Pacific
-
1. What services does ClinActis provide as a contract research organisation (CRO)?ClinActis is an Asia-based full-service contract research organisation (CRO) that offers a wide range of services, including site feasibility and selection, clinical project management, regulatory and ethics submissions, clinical and medical monitoring. Our services cater to the unique needs of biotech, pharmaceutical, medical device, and medical nutrition companies. By supporting clients throughout every phase of the clinical trial process, we ensure high-quality and efficient execution.
-
2. Which companies and industries does ClinActis serve?ClinActis provides tailored solutions to companies across several industries, including biotech, pharmaceutical, medical device, and medical nutrition. We understand the unique requirements of each sector, ensuring our clinical trial services meet the specific needs of your business. Whether you're a startup or an established enterprise, our expertise ensures effective trial outcomes.
-
3. What is a contract research organisation (CRO), and how does ClinActis add value?A contract research organisation (CRO) is an external partner that manages clinical trials for pharmaceutical, biotech, and medical device companies. ClinActis adds value by combining global clinical trial and medical research expertise with a deep local knowledge of the Asia-Pacific (APAC) region. Our familiarity with local regulations, investigators, and sites ensures faster, more efficient trials and successful outcomes.
-
4. How does ClinActis ensure data quality in clinical trials?As a dedicated medical research company, ClinActismaintains data quality through rigorous study design, careful site selection, and precise data collection. Regular monitoring ensures that data integrity is upheld throughout the trial. Adhering to strict regulatory standards, we guarantee that all results are reliable, compliant, and reflective of the highest standards of clinical research.
-
5. What is ClinActis' geographical coverage for clinical research services?ClinActisprovides clinical research project management services across the Asia-Pacific region, with capabilities in Singapore, South Korea, Mainland China, Japan, Australia, New Zealand, Malaysia, Thailand, Hong Kong, Taiwan, The Philippines, and India. This extensive reach allows us to provide clinical trial services in diverse markets, ensuring a comprehensive approach to trial management in the region.
-
6. How does ClinActis support clinical research project management in APAC?ClinActis supports clinical research project management in the APAC region by offering end-to-end coordination of clinical trials in Asia, ensuring efficiency, compliance, and seamless execution. Our experienced project managers handle all aspects of the trial process, including setting timelines, managing resources, and navigating regulatory requirements specific to APAC. With a deep understanding of both international standards and the unique clinical trial environment across the region, we help ensure that projects remain on schedule, on budget, and fully compliant.
-
7. How can partnering with ClinActis reduce the cost of clinical trials?Partnering with ClinActis can significantly reduce the cost of clinical trials by providing cost-effective solutions specifically tailored to the APAC region, which has become an attractive destination for US-based sponsors seeking global trial expansion. We optimise trial strategies in Asia Pacific and streamline operational processes to maximize value. By leveraging our local expertise and extensive network in APAC, we identify cost-efficient sites and resources that minimize overall expenses while ensuring trial quality and regulatory compliance. For US companies looking to expand their research, ClinActis offers access to diverse patient populations and a favourable regulatory environment, providing an effective way to conduct global trials while reducing costs and timelines.
-
8. What sets ClinActis apart from other contract research organisations (CROs)?ClinActis differentiates itself from other contract research organisations (CROs) through its blend of global clinical trial experience and extensive local knowledge within the APAC region. We are exclusively focused on conducting trials in APAC. Our ability to navigate complex regulatory environments, local clinical site networks, local cultures and to collaborate with local KOLs enables us to deliver high-quality, tailored services to clients, ensuring the successful delivery of every trial.
-
9. How does ClinActis ensure regulatory compliance in clinical trials in APAC?At ClinActis, we ensure full regulatory compliance for clinical trials in APAC by staying aligned with both local regulations and international standards, including those set by US government agencies like the Food and Drug Administration (FDA). Our team works closely with local authorities across Asia Pacific to ensure that trials comply with all necessary legal requirements, avoiding delays and ensuring smooth trial execution. This approach guarantees that our clinical research is conducted to the highest ethical, safety, and quality standards, making it easier for US-based sponsors to expand globally while maintaining compliance with FDA and other relevant international guidelines.
-
10. How can I get in touch with ClinActis to learn more?You can reach ClinActis by visiting the Contact Us page on our website. Whether you’re looking for more information about our services or want to discuss a specific clinical trial project, our team is available to assist. We’re ready to provide expert guidance and tailored solutions to ensure the success of your clinical research initiatives
-
11. How does ClinActis manage logistics and compliance across Asia?As a leading contract research organisation (CRO) in Asia, ClinActis expertly navigates the region's strict customs regulations using deep local knowledge of import procedures and customized distribution strategies. We ensure smooth operations for clinical trials in APAC by preventing delays and facilitating seamless logistics management, which is particularly crucial for US-based sponsors requiring efficient trial operations abroad. Our approach aligns with U.S. Food and Drug Administration (FDA) standards where applicable, ensuring that clinical supplies and processes meet the quality and compliance needs of international sponsors. This strategic logistics management helps maintain the integrity, safety, and timely progress of all clinical studies within APAC.
NEWS
November 2, 2022
In the last 10 years, APAC has become a hotspot for clinical trials: the region contributed almost 50% of new clinical trial activity globally in 2021.
It is often said that “disease knows no borders,” but is the same true for clinical development? Patient availability is a critical component for clinical trials, and so it stands to reason that clinical development should match the epidemiology of diseases. Of course, this is often not the case, with longstanding biases towards studies in the US and Europe, where health care infrastructure and the pharmaceutical market are generally more mature. However, change is underway.
May 15, 2022
According to GlobalData, of the trials planned for 2022 (data as of 15 May 2022) APAC region has the bulk of the clinical trials with 54%, followed by North America and Europe at 27% and 20%, respectively. As per the information available in GlobalData’s Pharma Intelligence Center’s Clinical Trials Database, there are 2,430 trials planned for 2022 in APAC as of 15 May 2022.
March 12, 2019
ClinActis Selected as Top 10 CRO in Asia 2019
ClinActis has been a leading CRO in Asia since 2009, providing high-quality international clinical research expertise to our clients. With our global trial experience and local knowledge, we bring a unique perspective and expertise to the region, standing out as a trusted provider of international clinical trial quality standards in Asia Pacific.